GT
Galvanize Therapeutics, Inc.
SEC filingBiotechnology · Redwood City, CA
Amount raised$96.1Msold at filing
Total offering$141.1M$44.9M still open
Investors in the raise28count reported to the SEC
FiledSep 11, 2025first sale Jul 7, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Doug GodshallExecutive Officer, Director
Jonathan WaldstreicherExecutive Officer
Antoine PapiernikDirector
David LewisDirector
Steve AnheierExecutive Officer
Seth HarrisonDirector
Zack ScottDirector
Executive officers, directors and promoters as listed on the Form D.